Survival Prognosis in Very Old Adults (2024)

  • Journal List
  • HHS Author Manuscripts
  • PMC4749674

As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsem*nt of, or agreement with, the contents by NLM or the National Institutes of Health.
Learn more: PMC Disclaimer | PMC Copyright Notice

Survival Prognosis in Very Old Adults (1)

About Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;

J Am Geriatr Soc. Author manuscript; available in PMC 2016 Feb 11.

Published in final edited form as:

J Am Geriatr Soc. 2016 Jan; 64(1): 81–88.

doi:10.1111/jgs.13838

PMCID: PMC4749674

NIHMSID: NIHMS755104

PMID: 26782855

Mikael Thinggaard, MSc,* Matt McGue, PhD, Bernard Jeune, MD,* Merete Osler, MD, PhD,*§ James W. Vaupel, PhD,*# and Kaare Christensen, MD, PhD***

Author information Copyright and License information PMC Disclaimer

The publisher's final edited version of this article is available at J Am Geriatr Soc

Associated Data

Supplementary Materials

Abstract

OBJECTIVES

To determine whether simple functional indicators are predictors of survival prognosis in very old adults.

DESIGN

In-person survey conducted over a 3-month period in 1998; assessment of survival over a 15-year follow-up period.

SETTING

Denmark.

PARTICIPANTS

All 3,600 Danes born in 1905 and living in Denmark in 1998, were invited to participate regardless of residence and health; 2,262 (63%) participated in the survey: 1,814 (80.2%) in person and 448 (19.8%) through a proxy.

MEASUREMENTS

Socioeconomic factors, medications and diseases, activities of daily living, physical performance, cognition, depression symptomatology, self-rated health, and all-cause mortality, evaluated as average remaining lifespan and chance of surviving to 100 years.

RESULTS

Men aged 92 to 93 had an overall 6.0% chance of surviving to 100 years, whereas the chance for women was 11.4%. Being able to rise without use of hands increased the chance for men to 11.2% (95% confidence interval (CI) = 7.7–14.7) and for women to 22.0% (95% CI = 18.9–25.1). When combining this with a Mini-Mental State Examination (MMSE) scores from 28 to 30, the chances were 21.7% (95% CI = 11.5–31.9) for men and 34.2% (95% CI = 24.8–43.5) for women.

CONCLUSION

Chair stand score combined with MMSE score is a quick and easy way to estimate overall chance of survival in very old adults, which is particularly relevant when treatment with potential side effects for nonacute diseases is considered. J Am Geriatr Soc 64:81–88, 2016.

Keywords: mortality, nonagenarians, clinical decision, chair stand, Mini-Mental State Examination

The chance of surviving to the age of 90 has increased markedly over the last 50 years in high-income countries, and will probably continue to rise with successive cohorts.1,2 In the United States, the number of nonagenarians has increased from approximately 230,000 in 1960 to approximately 1.8 million in 2010, and in the five biggest countries in the European Union (Germany, France, the United Kingdom, Italy, Spain) the number has increased from approximately 250,000 to 1.6 million, which is almost 7 times as many nonagenarians, compared with 1.5 times as many people in the total population of these countries in 1960 as in 2010.

With this growing number of oldest old adults, ageism has been decreasing in recent decades, and it has now become generally unacceptable to deny medical procedures to people aged 80 and older using advanced age as the sole argument.3 Research has also emerged that investigates medical procedures for very old adults,46 but life expectancy for very old adults is still short in most high-income countries, ranging from around 8 to 10 years for 80-year-olds to 4 to 5 years for 90-year-olds (online Table S1).7 Hence, overtreatment of very old adults is still a general concern, and potential side effects of treatment have to be balanced with the overall survival prognosis, which is generally based on the overall chance of survival to a given age or overall life expectancy.8 It has been argued that clinicians should offer to discuss the overall survival prognosis with patients aged 85 and older.8 There is large varivariation in health and life expectancy in very old adults, which also should be taken into consideration before treatment is provided. Comprehensive geriatric assessments exist, but they are generally time-consuming and mostly validated in people aged 70 to 80.9-11 Simple, easy-to-use tools that can help predict the chance of individual survival in very old adults would be useful in clinical decision-making for general practitioners, but only a few studies have investigated factors that predict mortality in very old adults. In a study of 186 Spanish nonagenarians, comorbidity and cognition assessed over a 5-year follow-up period were found to be the best predictors of mortality.12 In a study of 888 Finnish people aged 90 and older, activities of daily living (ADLs), self-rated health, and being institutionalized over a 9-year period were found to be associated with mortality.13 A study of 19,340 Americans, 335 of whom were nonagenarians, showed that functional limitation in nonagenarians was a better predictor of mortality than chronic conditions.14 In a study of 335 Italian people aged 80 and older, walking speed and five-time chair stand test were found to be associated with mortality.15 Walking speed and chair stands has also been shown to predict subsequent disability and mortality in people aged 70 and older.16,17 Unfortunately, most of these studies presented hazard ratios, which can be difficult to use in clinical decision-making and to communicate to people.

This study comprised a Danish birth cohort followed from age 92 or 93 until the cohort was almost extinct. The aim was to identify measures that predict remaining lifespan and chance of surviving to 100 years and that can be easily administered in a primary care setting without specialized equipment.

METHODS

Study Population and Measures

The study population comprised all people born in 1905 who were alive in 1998 and living in Denmark at the time of the survey, which took place from August to October. They were all invited to participate, regardless of residence, health, or cognitive status, giving a total of 3,600 people, 2,262 (62.8%) of whom participated: 1,814 (80.2%) in person and 448 (19.8%) through a proxy. Interviewers from a survey agency interviewed participants in their homes. The study instrument consisted of an interview, physical and cognitive tests, and a deoxyribonucleic acid sample. The ethical committee system in Denmark approved the study (Trial VF20040240), and all participants provided informed consent to participate. The study has been described in detail previously and is a follow-up of a study that showed that disability and cognitive impairment predicted mortality over 15 months.1820 The selected variables in this study were measures of socioeconomic factors, medications and diseases, ADLs, physical performance (chair stand, grip strength, walking speed), cognition (Mini-Mental State Examination (MMSE), composite of five cognitive tests sensitive to age-related changes), depression symptomatology, and self-rated health. The measures were chosen based on the criterion that they have generally been used to predict mortality in individuals aged 70 and older. Online Appendix S1 describes these measures in detail.

Survival

All members of the Danish 1905 cohort were followed from the baseline interview period through January 1, 2013, in the Danish Civil Registration system, which registers date of death or emigration of all Danish citizens.21 Only two persons emigrated in the follow-up period and were lost to follow-up at the emigration date.

Statistical Analysis

Multivariable logistic regression analyses were performed to assess the association between the many potential measures for a 92- or 93-year-old person and the chance of surviving to 100 years. C-statistics (area under the receiver operating curve) were estimated from the multivariable logistic regressions to assess the ability of these measures to predict the chance of surviving to 100. C-statistics range from 0.5 and 1 and are a rough guide for classifying the prediction of the outcome (0.5–0.6 = failed prediction, 0.6–0.7 = poor prediction, 0.7–0.8 = fair prediction, 0.8–0.9 = good prediction, 0.9–1 = excellent prediction). Because there was an exact age at death for all members of the cohort except for six persons (0.1%), the average remaining lifespan was simply calculated as mean time to death, emigration, or time to January 1, 2013. Because only two persons (0.06%) emigrated, and four (0.1%) were still alive after January 1, 2013, the above measures would essentially be unbiased. All analyses were performed separately for each sex, and because the age range was 92 to 93, and 80% were aged 92.8 to 93.6, adjusting for age was not necessary.

Multiple imputation using a full conditional specification model (chained equation) in the analysis was used to account for missing data, which was mainly due to the interview being conducted through a proxy or the 1905 cohort member being physically or mentally unable to perform the tests.22Online Appendix S1 describes the multiple imputation in detail. Statistical analysis was performed using Stata version 13.1 (Stata Corp, College Station, TX).

RESULTS

The prevalence of indicators of poor health was generally high and higher in women than men, except for myocardial infarction (Table 1). Over the 15-year follow-up from 1998, four (0.1%) of the 3,600 persons were still alive, and only two (0.06%) were lost to follow-up due to emigration. Men had a significantly lower average remaining lifespan than women (2.7 vs 3.3 years, P < .001), and men had a 6.0% chance of surviving to 100 years, whereas the chance for women was almost twice as high (11.4%). Nonparticipation, in-person interview, and proxy interview were significantly associated with mortality. Male nonparticipants had a 4.2% chance (95% confidence interval (CI) = 2.1–7.3) of surviving to 100 years, those interviewed in person had an 8.1% chance (95% CI = 5.8– 10.9), and those interviewed through a proxy had a 0% chance (95% CI = 0.0–4.0). For women, the chances of surviving to 100 years were 9.4% (95% CI = 7.7–11.3) for nonparticipants, 15.6% (95% CI = 13.7–17.7) for in-person interviewees, and 1.7% (95% CI = 0.6–3.6) for proxy interviewees.

Table 1

Description of the Sample and Estimated Prevalence of Selected Measures at Age 92 to 93 for the Danish 1905 Birth Cohort (N = 2,262)

Men, n = 584Women, n = 1,678
Factorn (%)Missing,
n (%)
Estimated
Prevalence,
% (95% CI)
n (%)Missing,
n (%)
Estimated
Prevalence,
% (95% CI)
Socioeconomic factors
 Elementary school education271 (48.6)26 (4)48.3 (44.1–52.5)1,204 (74.1)54 (3)74.0 (71.8–76.1)
 Social class IV–Va238 (41.8)14 (2)41.7 (37.7–45.8)1,359 (83.0)40 (2)82.9 (81.1–84.8)
 Body mass index <22 kg/m2154 (26.8)10 (2)27.0 (23.4–30.7)734 (45.4)62 (4)45.5 (43.1–47.9)
 Smoking (now)142 (24.8)12 (2)24.9 (21.3–28.4)170 (10.3)30 (2)10.3 (8.9–11.8)
Disease (present or prior)
 Cancer31 (5.3)2 (0.3)5.3 (3.5–7.1)135 (8.1)13 (1)8.1 (6.8–9.4)
 Chronic bronchitis53 (9.1)2 (0.3)9.2 (6.8–11.5)172 (10.3)11 (1)10.4 (8.9–11.8)
 Myocardial infarction47 (8.1)1 (0.2)8.1 (5.8–10.3)96 (5.8)15 (1)5.8 (4.6–6.9)
 Stroke71 (12.2)2 (0.3)12.3 (9.6–15.0)189 (11.3)19 (2)11.5 (9.9–13.0)
ADLs
 ADL score < 1.3141 (26.4)49 (8)26.3 (22.7–30.0)636 (40.9)123 (7)40.0 (37.6–42.4)
 Katz severely disabled108 (18.7)6 (1)18.9 (15.7–22.1)352 (21.3)27 (2)21.5 (19.5–23.4)
 Katz moderately disabled180 (31.1)6 (1)31.1 (27.3–34.9)625 (37.9)27 (2)37.9 (35.6–40.2)
Physical condition
 Not able to stand from a chair33 (6.9)109 (19)11.5 (8.4–14.6)99 (7.9)428 (26)15.9 (13.7–18.1)
 Able to stand from a chair with use of hands154 (32.4)109 (19)35.0 (30.7–39.3)529 (42.3)428 (26)42.8 (40.0–45.6)
 Grip strength 1–18 kg in men, 1–10 kg in women118 (25.6)123 (21)29.6 (25.3–33.9)312 (26.7)508 (30)30.1 (27.4–32.7)
 Not able to walk55 (12.9)121 (21)19.3 (15.7–22.9)144 (13.0)459 (27)21.2 (18.8–23.5)
Cognition
 MMSE score 0–1761 (14.3)158 (27)19.0 (15.3–22.6)234 (20.7)546 (33)26.8 (24.1–29.4)
 MMSE score 18–23127 (30)158 (27)33.4 (29.1–37.7)365 (32)546 (33)35.4 (32.5–38.4)
 Fluency 0–7 words76 (16.4)76 (13)24.1 (19.0–29.1)283 (22.9)283 (17)32.9 (29.4–36.4)
 Cognitive composite score <-0.5 standard deviations91 (21.5)160 (27)33.4 (28.5–38.3)237 (21.4)568 (34)34.1 (30.8–37.5)
Depression symptomatology and self-rated health
 Depression symptomatology (29–52)103 (25.1)174 (30)32.5 (28.3–36.6)316 (28.4)565 (34)37.3 (34.4–40.1)
 Self-rated health very poor to poor51 (10.3)160 (27)12.5 (9.3–15.8)153 (11.6)568 (34)14.3 (12.1–16.4)
Apolipoprotein E ε4 carrier99 (21.7)127 (22)21.6 (17.8–25.4)255 (21.9)514 (31)21.8 (19.4–24.2)

Open in a separate window

Prevalence was estimated using multiple imputation analysis to take into account missing values.

CI = confidence interval; ADL = activity of daily living; MMSE = Mini-Mental State Examination.

aHousewives, nonskilled workers, smallholders and employees without subordinates, with no further education and a job demanding no expertise.

All ADL, physical condition, cognitive, depression symptomatology, and self-rated health measures were significantly associated with average remaining lifespan and chance of surviving to 100 years when analyzed separately for men and women (Figures 1 and ​and2).2). Within each category of ADLs and physical and cognitive ability, the measures had almost the same association with chance of surviving to 100 years and average remaining lifespan. Belonging to the category with the best ADL, physical condition, cognitive, depression symptomatology, or self-rated health measurement resulted in an absolute gain of 0.8 to 1.7 years. Being able to rise from a chair without using hands increased the chance of surviving to 100 years to 11.2% (95% CI = 7.7–14.7) for men and 22.0% (95% CI = 18.9–25.1) for women from 1.5% for men and 2.4% for women who could not do so. With regard to cognition, the chance of surviving to 100 for men with an MMSE score of 24 or greater was 11.2% (95% CI = 7.9–15.5), and the chance for women was 19.3% (95% CI = 16.3– 22.6); whereas it was 2.9% for men and 8.6% for women with an MMSE score of less than 24. Body mass index (BMI), number of medications, stroke, and apolipoprotein E were also associated with survival, although the associations for these measures were not as strong as for the ADL, physical condition, cognitive, depression symptomatology, and self-rated health measures. Socioeconomic condition, smoking, cancer, chronic bronchitis, and myocardial infarction were not associated with mortality.

Open in a separate window

Figure 1

Average remaining lifespan estimated using multiple imputation. The categories are the same for all measures for both sexes except for grip strength, as indicated in the figure. Bars indicate 95% confidence intervals.

Open in a separate window

Figure 2

Chance of surviving to 100 estimated using multiple imputation. The categories are the same for all measures for both sexes except for grip strength, as indicated in the figure. Bars indicate 95% confidence intervals.

The full multivariable logistic regressions showed that the chance of surviving to 100 was most strongly associated with ADL, physical condition, and cognitive measures (Table 2). The c-statistic was estimated to be 0.86 (95% CI = 0.81–0.92) for men and 0.79 (95% CI = 0.76–0.82) for women. In the logistic regressions with only one ADL and physical condition measure and one cognitive measure, the c-statistics ranged from 0.74 to 0.81 for men and from 0.70 to 0.75 for women. For the chair stand and the MMSE, the c-statistic was 0.77 (95% CI = 0.71–0.84) for men and 0.73 (95% CI = 0.70–0.77) for women. Given different groupings of chair stand and MMSE score, the prevalence of persons in the group, the chance of surviving to 100, and average remaining lifespan is shown in Table 3. The chance of surviving to 100 when an individuals was able to rise from a chair without using the hands and had an MMSE score of 24 or greater was 14.0% (95% CI = 9.8–19.7) for men and 27.3% (95% CI = 23.0–32.2) for women. The average remaining lifespan for this group was 3.7 years (95% CI = 3.3–4.1) for men and 5.1 years (95% CI = 4.8–5.4) for women. This group constituted 33% of all men and 22% of all women. The likelihood of reaching 100 increased to 21.7% and average remaining lifespan increased to 4.3 years for men who were able to rise from a chair without using the hands and had an MMSE score of 28 or greater and to 34.2% and 5.6 years, respectively, for women. Replacing the chair stand with Katz disability in this combination showed similar results (Table 3).

Table 2

Multivariable Logistic Regression Using Multiple Imputation Analysis Assessing Chance of Surviving to 100 According to Sex

MenWomen
FactorOR (95% CI)P-ValueaOR (95% CI)P-Valuea
Socioeconomic factors.33.004
 Education (1-category increase)0.60 (0.33–1.09)0.90 (0.66–1.23)
 Social class (1-category increase)1.43 (0.82–2.50)0.94 (0.66–1.35)
 Body mass index > 22.0 kg/m21.66 (0.66–4.19)1.81 (1.29–2.54)
 Never smoker0.60 (0.22–1.64)0.84 (0.60–1.17)
Disease and medication.54.48
 Medication (1-unit increase)0.94 (0.77–1.14)0.95 (0.88–1.02)
 Number of diseases (1-unit increase)0.92 (0.73–1.16)1.02 (0.94–1.11)
 Never had cancer0.87 (0.48–1.57)
 Never had chronic bronchitis1.29 (0.33–5.05)1.56 (0.85–2.87)
 Never had myocardial infarction1.60 (0.34–7.57)1.16 (0.58–2.34)
 Never had stroke2.87 (0.34–23.97)1.34 (0.70–2.58)
ADLs.002.01
 ADL score (1-unit increase)2.92 (1.44–5.90)1.33 (0.97–1.85)
 Katz disability (1-category increase)1.75 (0.63–4.87)1.41 (1.00–1.99)
Physical condition.23.003
 Chair stand (1-category increase)1.76 (0.62–5.03)1.45 (0.98–2.13)
 Grip strength (1-unit increase)1.01 (0.95–1.08)1.03 (0.99–1.08)
 Walking (1-category increase)0.45 (0.20–1.02)1.50 (1.03–2.17)
Cognition.02.003
 Mini-Mental State Examination (1-unit increase)1.12 (0.99–1.27)1.02 (0.98–1.06)
 Cognitive Composite Score (1-unit increase)1.08 (0.95–1.22)1.08 (1.01–1.14)
Depression symptomatology and self-rated health.18.71
 Depression symptomatology (1-unit increase)0.99 (0.91–1.08)0.99 (0.95–1.02)
 Self-rated health (1-category increase)0.52 (0.26–1.05)0.90 (0.67–1.21)
Apolipoprotein E ε4 noncarrier2.35 (0.83–6.63).111.82 (1.17–2.83).008

Open in a separate window

aP-value is from a joint test of the variables in the category being able to predict the chance of surviving to 100.

OR = odds ratio; CI = confidence interval; ADL = activity of daily living.

Table 3

Combined Results of Chair Stand and Mini-Mental State Examination or Chair Stand and Activity of Daily Living Disability According to Sex

Test

MenWomen
Prevalence
at Age
92–93, %
Likelihood
of Reaching
100, %
Average
Remaining
Lifespan,
Years (Relativea)
Prevalence
at Age
92–93, %
Likelihood
of Reaching
100, %
Average
Remaining
Lifespan,
Years (Relativea)
Chair standMMSE score
 Cannot0–30121.51.4 (0.5)162.41.8 (0.5)
 Can with use of hands0–1780.01.8 (0.6)125.12.4 (0.7)
 Can with use of hands18–23141.32.1 (0.8)177.83.1 (0.9)
 Can with use of hands24–30134.03.0 (1.1)149.03.6 (1.1)
 Can without use of hands0–1763.02.0 (0.7)613.33.4 (1.0)
 Can without use of hands18–23158.13.3 (1.2)1417.24.2 (1.3)
 Can without use of hands24–272210.23.5 (1.3)1624.64.9 (1.5)
 Can without use of hands28–301121.74.3 (1.6)634.25.6 (1.7)
Katz disabilityMMSE score
 Severely disabled0–30190.91.4 (0.5)210.81.9 (0.6)
 Moderately disabled0–1760.02.0 (0.7)910.02.8 (0.8)
 Moderately disabled18–23122.82.3 (0.9)157.93.0 (0.9)
 Moderately disabled24–30132.72.7 (1.0)1413.63.9 (1.2)
 Not disabled0–1744.02.4 (0.9)512.23.4 (1.0)
 Not disabled18–23137.73.3 (1.2)1318.54.4 (1.3)
 Not disabled24–272111.73.6 (1.3)1621.44.6 (1.4)
 Not disabled28–301220.14.5 (1.7)632.25.6 (1.7)

Open in a separate window

Analyses were performed using multiple imputation.

aRelative to overall average remaining lifespan: 2.7 for men, 3.3 for women.

MMSE = Mini-Mental State Examination.

Multiple imputation was used in all analyses. Analysis of the data using only complete case analysis would have generated bias for the measures with many missing data mainly due to interviews being conducted through a proxy, which was 19.8% of all interviews (Table 1, Online Table S2), but there were very few missing data for the majority of the measures (e.g., for Katz disability, socioeconomic position, BMI), and for these measures, the results were virtually identical between complete case analysis and multiple imputation.

DISCUSSION

Basic physical and cognitive measures are highly informative in predicting chance of survival in very old adults. At the age of 92 or 93, men who were able to rise from a chair without using hands had an 11% chance and women a 22% chance of surviving to 100; men and women who were unable to do so had a 2% chance. Being able to rise from a chair without using hands and having an MMSE score of 28 or greater, one in five men and one in three women would reach the age of 100. This was three times as high a likelihood as the general likelihood for men and women.

Questions about Katz disability would be an alternative to the chair stand because it had an effect size similar to that of the chair stand. A multivariable model also showed that the measures investigated in this study were suitable for differentiating individuals aged 92 to 93 who lived to become 100 from those who did not. Socioeconomic condition, smoking, cancer, chronic bronchitis, and myocardial infarction were not associated with mortality in these very old adults. It is likely that this lack of association was due to selection (e.g., individuals with low socioeconomic status or smokers who survive to very old age are robust).23 A previous study showed that smokers aged 80 and older had inflammation and lung function levels similar to those who had never smoked and no difference in mortality.24

These results are in line with those of other studies,1215 but the results of these studies were presented in a manner that made it difficult to interpret the chance of individual survival. The current study examined easily interpreted measures such as chance of surviving to 100 and average remaining lifespan for individuals aged 92 to 93, which is possible because of the availability of a large sample from one birth cohort.

A strength of this study is that information on date of death and emigration for all members of the Danish 1905 cohort was obtained through the Danish Civil Registration system and that all persons were invited to participate in the health survey in 1998, regardless of residence, health, or cognitive status. Another strength of the study is that proxy participants were encouraged to participate in the interview if the nonagenarian was unable to participate because of mental or physical disabilities, making lack of information on the most disabled individuals less problematic. Moreover, the use of multiple imputation with information from proxies and nonproxies makes inference about the association between the measures, which were measured only in nonproxies, and mortality less biased. Handling of missing data using multiple imputation is important in clinical trials and observational studies.25

A weakness of the study is that it includes only one birth cohort from one country. Hence, an important question is whether the results can be generalized to other countries and younger birth cohorts, but the measures are well validated and used across high-income countries where life expectancy for nonagenarians is fairly hom*ogenous (Online Table S1), and the use of relative estimates is likely to ensure generalizability for other countries and newer cohorts. Another potential problem is that, even though the participation rate from the health survey was high (63%), nonresponse from the frailest individuals could create biased associations. Using data from the Danish Civil Registration system, the participants were compared with the nonparticipants, and it was found that the nonparticipants had a shorter average remaining lifespan that the survey participants, indicating that the prevalence of poor health was higher than stated in this manuscript and that the average remaining lifespan of people performing poorly is probably overestimated. The average remaining lifespan of those performing well would most likely not be biased.

Ageism in treatment of very old adults who are well functioning has decreased over the last decade, and medical procedures for this age group have been examined,4,5 but overtreatment of very old adults is of concern, and potential side effects and complications associated with treatment must be balanced with the overall survival prognosis.8 The life expectancy for an 80-year-old ranges from 8 to 10 years in high-income countries but is still fairly short for 90-year-olds, ranging from 4 to 5 years. Comprehensive geriatric assessment instruments aim to identify current health problems and assist in medical decision-making,6,9 but they are generally time-consuming. Simpler screening tools exist, but the have mostly been validated in people aged 70 to 80.10,11

For nonagenarians, being able to rise from a chair without using hands and having an MMSE score of 28 or greater, the average remaining lifespan was 1.6 to 1.7 times as high as that for men and women in general. Translating this to the life expectancy seen in Denmark in 2009 to 2012 would indicate a life expectancy today of 6.3 years for men and 7.7 years for women at age 92 to 93. Chair stand score combined with MMSE score is a quick and easy way to estimate overall chance of survival in very old adults, which is important to take into consideration when making major clinical decisions.

Supplementary Material

Supplement material

Click here to view.(154K, doc)

ACKNOWLEDGMENTS

The authors wish to thank Karen Andersen-Ranberg, MD, for helpful input and discussion during the conduction of this study.

The Danish 1905 cohort survey was supported by grants from the Danish National Research Foundation and U.S. National Institutes of Health, National Institute on Aging Grant NIA-P01-AG08761. The Danish Aging Research Center is supported by a grant from the VELUX foundation.

Footnotes

Conflict of Interest

We declare that we have no conflicts of interest.

Author Contributions

Thinggaard: data analysis, drafting the manuscript. Christensen, Jeune, Vaupel: study initiation, obtaining funding, drafting the manuscript. McGue: protocol design, data analysis, drafting the manuscript. Osler: obtaining funding, data analysis, drafting the manuscript. All authors read and approved the final version.

Sponsor’s Role

The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.

SUPPORTING INFORMATION

Additional Supporting Information may be found in the online version of this article:

Appendix S1 Extended description of the selected measures in this study and a more in-depth description of the multiple imputation used in the statistical analysis.

Table S1 Life expectancy (period mortality).

Table S2 Chance of surviving to 100 years for selected measures at 92–93 years of age using complete case analysis.

REFERENCES

1. Christensen K, Doblhammer G, Rau R, et al. Ageing populations: The challenges ahead. Lancet. 2009;374:1196–1208. [PMC free article] [PubMed] [Google Scholar]

2. Christensen K, Thinggaard M, Oksuzyan A, et al. Physical and cognitive functioning of people older than 90 years: A comparison of two Danish cohorts born 10 years apart. Lancet. 2013;382:1507–1513. [PMC free article] [PubMed] [Google Scholar]

3. Boon NA. New deal for old hearts. BMJ. 1991;303:70. [PMC free article] [PubMed] [Google Scholar]

4. Alfonso DT, Howell RD, Strauss EJ, et al. Total hip and knee arthroplasty in nonagenarians. J Arthroplasty. 2007;22:807–811. [PubMed] [Google Scholar]

5. George I, Yerebakan H, Kalesan B, et al. Age alone should not preclude surgery: Contemporary outcomes after aortic valve replacement in nonagenarians. J Thorac Cardiovasc Surg. 2014;148:1360–1369.e1. [PubMed] [Google Scholar]

6. Rivoirard R, Chargari C, Trone JC, et al. General management of nonagenarian patients: A review of the literature. Swiss Med Wkly. 2014;144:w14059. [PubMed] [Google Scholar]

7. Human Mortality Database [on-line] Available at http://www.mortality.org/Accessed July 11, 2014.

8. Smith AK, Williams BA, Lo B. Discussing overall prognosis with the very elderly. N Engl J Med. 2011;365:2149–2151. [PMC free article] [PubMed] [Google Scholar]

9. Extermann M, Aapro M, Bernabei R, et al. Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG) Crit Rev Oncol Hematol. 2005;55:241–252. [PubMed] [Google Scholar]

10. Decoster L, Van Puyvelde K, Mohile S, et al. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: An update on SIOG recommendations. Ann Oncol. 2015;26:288–300. [PubMed] [Google Scholar]

11. Yourman LC, Lee SJ, Schonberg MA, et al. Prognostic indices for older adults: A systematic review. JAMA. 2012;307:182–192. [PMC free article] [PubMed] [Google Scholar]

12. Formiga F, Ferrer A, Chivite D, et al. Predictors of long-term survival in nonagenarians: The NonaSantfeliu study. Age Ageing. 2011;40:111–116. [PubMed] [Google Scholar]

13. Tiainen K, Luukkaala T, Hervonen A, et al. Predictors of mortality in men and women aged 90 and older: A nine-year follow-up study in the Vitality 90+ study. Age Ageing. 2013;42:468–475. [PubMed] [Google Scholar]

14. Lee SJ, Go AS, Lindquist K, et al. Chronic conditions and mortality among the oldest old. Am J Public Health. 2008;98:1209–1214. [PMC free article] [PubMed] [Google Scholar]

15. Cesari M, Onder G, Zamboni V, et al. Physical function and self-rated health status as predictors of mortality: Results from longitudinal analysis in the ilSIRENTE study. BMC Geriatr. 2008;8:34. [PMC free article] [PubMed] [Google Scholar]

16. Guralnik JM, Ferrucci L, Simonsick EM, et al. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332:556–561. [PMC free article] [PubMed] [Google Scholar]

17. Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85–M94. [PubMed] [Google Scholar]

18. Nybo H, Gaist D, Jeune B, et al. The Danish 1905 cohort: A genetic-epidemiological nationwide survey. J Aging Health. 2001;13:32–46. [PubMed] [Google Scholar]

19. Nybo H, Gaist D, Jeune B, et al. Functional status and self-rated health in 2,262 nonagenarians: The Danish 1905 Cohort Survey. J Am Geriatr Soc. 2001;49:601–609. [PubMed] [Google Scholar]

20. Nybo H, Petersen HC, Gaist D, et al. Predictors of mortality in 2,249 nonagenarians—the Danish 1905-Cohort Survey. J Am Geriatr Soc. 2003;51:1365–1373. [PubMed] [Google Scholar]

21. Pedersen CB, Gotzsche H, Moller JO, et al. A cohort of eight million persons. Dan Med Bull. 2006;53:441–449. [PubMed] [Google Scholar]

22. Rubin DB. Multiple imputation after 18+ years. J Am Statistical Assoc. 1996;91:473–489. [Google Scholar]

23. Vaupel JW, Yashin AI. Heterogeneity’s ruses: Some surprising effects of selection on population dynamics. Am Stat. 1985;39:176–185. [PubMed] [Google Scholar]

24. Levine M, Crimmins E. Not all smokers die young: A model for hidden heterogeneity within the human population. PLoS One. 2014;9:e87403. [PMC free article] [PubMed] [Google Scholar]

25. Little RJ, D’Agostino R, Cohen ML, et al. The prevention and treatment of missing data in clinical trials. N Engl J Med. 2012;367:1355–1360. [PMC free article] [PubMed] [Google Scholar]

Survival Prognosis in Very Old Adults (2024)

FAQs

Survival Prognosis in Very Old Adults? ›

Men aged 92 to 93 had an overall 6.0% chance of surviving to 100 years, whereas the chance for women was 11.4%. Being able to rise without use of hands increased the chance for men to 11.2% (95% confidence interval (CI) = 7.7–14.7) and for women to 22.0% (95% CI = 18.9–25.1).

What is the prognosis for a 75 year old man? ›

In the pooled sample, median survival in years for the age groups 65 through 74 years was 12.6 for men and 16.8 for women; for 75 through 84 years, 7.9 for men and 10.5 for women; and for 85 years or older, 4.6 for men and 6.4 years for women (eTable 3).

What is the life expectancy of an 80 year old man? ›

The expectancy for the individuals in our birth cohort to be alive at age 80 and beyond was only in between 2.5–6% for males and 8.5–9.2% for females (see SCB, 2020).

What is the life expectancy of a 90 year old person? ›

What they found is that the Gompertz law goes a little haywire around the century mark. According to a press release, a 90 year old woman has a 15 percent chance of dying in the next year, and an estimated six years left to live.

How long will a 93 year old woman live? ›

SSA LIFE EXPECTANCY TABLES: FEMALE (AAM)
AgeLife Expectancy
914.53
924.20
933.90
943.63
38 more rows

What is the cause of death at 75 years old? ›

The major cause of death in the 55-64 age group is cancer followed by heart disease and injury. In the 75+ age group, the leading cause shifts to heart disease, and injury drops below Chronic Obstructive Pulmonary Disease (COPD), cerebrovascular diseases, and pneumonia.

What percentage of 80 year olds live to 90? ›

If you are an 80-year-old man, your long-term odds are not great. There is a 30 percent chance of making it to your 90th birthday, and only about 14 in 1,000 will see 100.

What percentage of men live past 80 years old? ›

What percentage of people live past 80? The answer is fairly complex , as it also has a lot to do with when you're born. Among those who are presently 80 years old (born in 1935), 40% of men and 57% of women are still around.

What are the odds of living to 85? ›

The Society of Actuaries (SOA) is the go-to resource. According to the SOA, a 65-year-old male today, in average health, has a 55% probability of living to age 85. For a 65-year-old woman, the probability of reaching 85 is 65%. Age 90 isn't some wild outlier.

What is the average age when a man dies? ›

Women's life expectancy was 79 years in the U.S. in 2021, while men's was about 73, according to CDC data. The U.S. has a higher rate of avoidable deaths, which is measured as death before the age of 75, among men than any comparable country.

What is the leading cause of death for 90 year olds? ›

Heart disease and cancer have been the two leading causes of death for persons 65 years of age and older for the past two decades, account- ing for nearly a million deaths in 2002. Nearly one-third of all deaths among older persons were due to heart disease, including heart at- tacks and chronic ischemic heart disease.

What is the most common cause of death in 90 year olds? ›

Heart disease remains the leading cause of death for most of the groups. Cancer is as common as heart disease within the youngest age group, 65-74 years of age, but decreases in importance with age, ranking third among women 85 years of age and older.

What percent of 90 year olds live to 100? ›

Equivalent to 6.9% of those alive at 90 reaching the milestone age of 100.

What are the odds of living to age 95? ›

In addition, there is a 34-per-cent chance that at least one of them will live until 95, and an 8-per-cent chance that one of them will make it to 100.

Is longevity inherited from mother or father? ›

Inheritance of lifespan may be also higher in the maternal than paternal line (15). Yet another explanation for the sex differences of associations between anthropometric traits of children and longevity of their parents might stem from different causes of death between the mothers and fathers of participants.

What is the strongest predictor of longevity? ›

Losing weight won't necessarily help you live longer, and the best predictors of a long and healthy life are mobility, strength and balance.

What is the leading cause of death in men over 75? ›

The top two causes of death for senior citizens in 2022 were heart diseases and cancer at 1,015.9 and 810.2 deaths per 100,000 people, respectively, according to provisional data from the Centers for Disease Control and Prevention (CDC).

What happens to your body after 75? ›

With age, bones tend to shrink in size and density, weakening them and making them more susceptible to fracture. You might even become a bit shorter. Muscles generally lose strength, endurance and flexibility — factors that can affect your coordination, stability and balance.

Is a 75 year old man old? ›

A third sub-grouping is young-old (65 to 74), old (74 to 84), and old-old (85+). Describing sub-groups in the 65+ population enables a more accurate portrayal of significant life changes.

Is 75 a low life expectancy? ›

Women's life expectancy was 79 years in the U.S. in 2021, while men's was about 73, according to CDC data. The U.S. has a higher rate of avoidable deaths, which is measured as death before the age of 75, among men than any comparable country.

Top Articles
Latest Posts
Article information

Author: Corie Satterfield

Last Updated:

Views: 5637

Rating: 4.1 / 5 (62 voted)

Reviews: 93% of readers found this page helpful

Author information

Name: Corie Satterfield

Birthday: 1992-08-19

Address: 850 Benjamin Bridge, Dickinsonchester, CO 68572-0542

Phone: +26813599986666

Job: Sales Manager

Hobby: Table tennis, Soapmaking, Flower arranging, amateur radio, Rock climbing, scrapbook, Horseback riding

Introduction: My name is Corie Satterfield, I am a fancy, perfect, spotless, quaint, fantastic, funny, lucky person who loves writing and wants to share my knowledge and understanding with you.